JS-201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JS-201, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer [Phase 2]